应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRVS Corvus Pharmaceuticals, Inc.
盘前交易 07-16 09:22:07 EDT
4.17
-0.18
-4.14%
盘前
4.14
-0.03
-0.72%
09:19 EDT
最高
4.38
最低
4.13
成交量
43.47万
今开
4.37
昨收
4.35
日振幅
5.75%
总市值
3.22亿
流通市值
2.62亿
总股本
7,711万
成交额
183.23万
换手率
0.69%
流通股本
6,293万
市净率
6.52
ROE
-100.13%
每股收益
-0.99
52周最高
10.00
52周最低
2.00
市盈率
-4.20
股息
0.00
股息收益率
0.00
ROA
-39.21%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Corvus Pharmaceuticals, Inc.盘中异动 临近收盘急速上涨5.02%
市场透视 · 07-14 19:57
Corvus Pharmaceuticals, Inc.盘中异动 临近收盘急速上涨5.02%
Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.05%报4.16美元
市场透视 · 07-09
Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.05%报4.16美元
Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.05%
市场透视 · 07-02
Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.05%
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%
市场透视 · 07-01
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.23%
市场透视 · 06-27
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.23%
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.09%
市场透视 · 06-24
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.09%
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.05%
市场透视 · 06-23
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.05%
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.00%
市场透视 · 06-12
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.00%
Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.20%报4.25美元
市场透视 · 06-10
Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.20%报4.25美元
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.20%报3.95美元
市场透视 · 06-05
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.20%报3.95美元
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.10%报3.91美元
市场透视 · 06-04
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.10%报3.91美元
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报3.97美元
市场透视 · 06-02
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报3.97美元
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.01%报3.67美元
市场透视 · 05-27
Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.01%报3.67美元
瑞穗银行:维持Corvus Pharma(CRVS.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至11.00美元。
金融界 · 05-20
瑞穗银行:维持Corvus Pharma(CRVS.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至11.00美元。
Corvus Pharmaceuticals, Inc.2025财年第一财季实现净利润15.19百万美元,同比增加366.49%
市场透视 · 05-17
Corvus Pharmaceuticals, Inc.2025财年第一财季实现净利润15.19百万美元,同比增加366.49%
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报3.76美元
市场透视 · 05-16
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报3.76美元
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报3.69美元
市场透视 · 05-14
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报3.69美元
Corvus Pharmaceuticals, Inc.股价拉升20.00% 市值涨5480.82万美元
市场透视 · 05-09
Corvus Pharmaceuticals, Inc.股价拉升20.00% 市值涨5480.82万美元
Corvus Pharma(CRVS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.13美元,前值为-0.12美元,预期值为-0.12美元。
金融界 · 05-08
Corvus Pharma(CRVS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.13美元,前值为-0.12美元,预期值为-0.12美元。
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报3.36美元
市场透视 · 05-08
Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报3.36美元
加载更多
公司概况
公司名称:
Corvus Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
2016-03-23
主营业务:
Corvus Pharmaceuticals, Inc.于2014年1月27日在特拉华州注册成立,并于2014年11月开始运作。该公司是一家临床阶段的生物制药公司,专注于发展和商业化那些旨在利用免疫系统攻击癌细胞的新免疫治疗肿瘤方案。自从2014年11月开始运营起,已建成四个免疫肿瘤的方案,其中三个重点腺苷癌症轴调节免疫反应的管道。该公司的主导候选产品,CPI-444,A2A受体腺苷,免疫检查点的口服小分子拮抗剂。
发行价格:
15.00
{"stockData":{"symbol":"CRVS","market":"US","secType":"STK","nameCN":"Corvus Pharmaceuticals, Inc.","latestPrice":4.17,"timestamp":1752609600000,"preClose":4.35,"halted":0,"volume":434667,"hourTrading":{"tag":"盘前","latestPrice":4.14,"preClose":4.17,"latestTime":"09:19 EDT","volume":32,"amount":132.48,"timestamp":1752671979550},"delay":0,"floatShares":62933308,"shares":77114636,"eps":-0.993816,"marketStatus":"盘前交易","change":-0.18,"latestTime":"07-16 09:22:05 EDT","open":4.37,"high":4.38,"low":4.13,"amount":1832310.050478,"amplitude":0.057471,"askPrice":4.22,"askSize":808,"bidPrice":4.14,"bidSize":983,"shortable":3,"etf":0,"ttmEps":-0.993816,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752672600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1458705600000,"exchange":"NASDAQ","adjPreClose":4.17,"preHourTrading":{"tag":"盘前","latestPrice":4.14,"preClose":4.17,"latestTime":"09:19 EDT","volume":32,"amount":132.48,"timestamp":1752671979550},"postHourTrading":{"tag":"盘后","latestPrice":4.14,"preClose":4.17,"latestTime":"18:41 EDT","volume":4664,"amount":19460.08,"timestamp":1752619297685},"volumeRatio":0.9677744706581249,"impliedVol":0.8324,"impliedVolPercentile":0.0924},"requestUrl":"/m/hq/s/CRVS","defaultTab":"news","newsList":[{"id":"2551135927","title":"Corvus Pharmaceuticals, Inc.盘中异动 临近收盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551135927?lang=zh_cn&edition=full","pubTime":"2025-07-15 03:57","pubTimestamp":1752523036,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日03时57分,Corvus Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.02%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司,致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715035717a44a8edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715035717a44a8edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2550657446","title":"Corvus Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.05%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550657446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550657446?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:52","pubTimestamp":1752083540,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日01时52分,Corvus Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.10%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司,致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710015221953c6a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710015221953c6a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2548819244","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548819244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548819244?lang=zh_cn&edition=full","pubTime":"2025-07-03 00:22","pubTimestamp":1751473337,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日00时22分,Corvus Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.75%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司,致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507030022179534231a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507030022179534231a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2548600058","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548600058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548600058?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:28","pubTimestamp":1751380119,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日22时28分,Corvus Pharmaceuticals, Inc.股票出现波动,股价快速跳水5.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司,致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012228399796034a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012228399796034a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2546744461","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546744461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546744461?lang=zh_cn&edition=full","pubTime":"2025-06-27 22:18","pubTimestamp":1751033882,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时18分,Corvus Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.23%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司,致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722180297917d64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722180297917d64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2545239866","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545239866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545239866?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:36","pubTimestamp":1750775796,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时36分,Corvus Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.09%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.03%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司,致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223637a4bbad2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223637a4bbad2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2545448376","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545448376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545448376?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:27","pubTimestamp":1750688845,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时27分,Corvus Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司,致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623222725a7190d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623222725a7190d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2543544778","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543544778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543544778?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:36","pubTimestamp":1749756993,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时36分,Corvus Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.涨幅较大,Nucana Plc、Polyrizon Ltd.、Klotho Neurosciences, Inc.较为活跃,换手率分别为3818.50%、925.68%、386.68%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.,振幅分别为256.24%、171.50%、102.43%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033633a705e5d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033633a705e5d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0},{"id":"2542969342","title":"Corvus Pharmaceuticals, Inc.盘中异动 大幅拉升5.20%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542969342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542969342?lang=zh_cn&edition=full","pubTime":"2025-06-11 03:06","pubTimestamp":1749582360,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日03时06分,Corvus Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.20%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.01%。其相关个股中,Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大,Nucana Plc、Windtree Therapeutics, Inc.、Carisma Therapeutics, Inc.较为活跃,换手率分别为35287.73%、2903.90%、1490.79%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Klotho Neurosciences, Inc.,振幅分别为261.54%、191.40%、120.05%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110306009779c064&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110306009779c064&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2541003355","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.20%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541003355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541003355?lang=zh_cn&edition=full","pubTime":"2025-06-06 03:05","pubTimestamp":1749150314,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日03时05分,Corvus Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.20%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Immatics N V C/Wts 01/07/2025 、Liminatus Pharma, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Nucana Plc、Eyenovia, Inc.较为活跃,换手率分别为1989.15%、958.08%、301.41%,振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Scinai Immunotherapeutics Ltd、Liminatus Pharma, Inc.,振幅分别为145.64%、142.06%、75.39%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606030514a49bd019&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606030514a49bd019&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2541959620","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.10%报3.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541959620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541959620?lang=zh_cn&edition=full","pubTime":"2025-06-05 02:58","pubTimestamp":1749063526,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日02时58分,Corvus Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.10%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Cellectar Biosciences, Inc.、Hoth Therapeutics, Inc.、Lyell Immunopharma, Inc.涨幅较大,Nucana Plc、Cellectar Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为1651.05%、1292.85%、620.20%,振幅较大的相关个股有Cellectar Biosciences, Inc.、Hoth Therapeutics, Inc.、Lyell Immunopharma, Inc.,振幅分别为106.81%、82.62%、61.90%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506050258469771da45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506050258469771da45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2540794511","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报3.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540794511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540794511?lang=zh_cn&edition=full","pubTime":"2025-06-02 23:35","pubTimestamp":1748878502,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日23时35分,Corvus Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.03%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.33%。其相关个股中,Lyra Therapeutics, Inc.、Nutriband Inc C/Wts 、Oragenics Inc.涨幅较大,Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为1632.52%、1110.04%、341.33%,振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为269.79%、111.83%、80.62%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602233502a496d717&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602233502a496d717&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2538246701","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.01%报3.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538246701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538246701?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:28","pubTimestamp":1748356085,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时28分,Corvus Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.01%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.35%。其相关个股中,Aeon Biopharma, Inc.、Forte Biosciences, Inc.、Gyre Therapeutics, Inc.涨幅较大,Nucana Plc、Aeon Biopharma, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为340.57%、87.79%、79.35%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为60.38%、60.00%、56.22%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527222805a48e81e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527222805a48e81e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2536524643","title":"瑞穗银行:维持Corvus Pharma(CRVS.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536524643","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536524643?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:41","pubTimestamp":1747748468,"startTime":"0","endTime":"0","summary":"瑞穗银行:维持Corvus Pharma(CRVS.US)评级,由优于大市调整至优于大市评级, 目标价由12.00美元调整至11.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/20214150545874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161121","CRVS"],"gpt_icon":0},{"id":"2536658261","title":"Corvus Pharmaceuticals, Inc.2025财年第一财季实现净利润15.19百万美元,同比增加366.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536658261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536658261?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497641,"startTime":"0","endTime":"0","summary":"5月18日,Corvus Pharmaceuticals, Inc.公布财报,公告显示公司2025财年第一财季净利润为15.19百万美元,同比增加366.49%;其中营业收入为0.00美元,每股基本收益为0.21美元。机构评级:截至2025年5月18日,当前有5家机构对Corvus Pharmaceuticals, Inc.目标价做出预测,其中目标均价为15.40美元,其中最低目标价为11.00美元,最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000315a4821e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000315a4821e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS"],"gpt_icon":0},{"id":"2535312874","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.03%报3.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535312874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535312874?lang=zh_cn&edition=full","pubTime":"2025-05-16 22:46","pubTimestamp":1747406790,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日22时46分,Corvus Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.03%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃,换手率分别为3743.15%、2227.51%、1171.91%,振幅较大的相关个股有Affimed N.V.、Vor Biopharma Inc.、Imunon, Inc.,振幅分别为466.98%、65.59%、42.74%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516224630a481098f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516224630a481098f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2535076523","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报3.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535076523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535076523?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:42","pubTimestamp":1747233766,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时42分,Corvus Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.17%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大,Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为3457.48%、3186.59%、1504.31%,振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Onconetix, Inc.,振幅分别为330.31%、162.34%、135.53%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514224246aa2c8e9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514224246aa2c8e9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2534522435","title":"Corvus Pharmaceuticals, Inc.股价拉升20.00% 市值涨5480.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534522435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534522435?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:31","pubTimestamp":1746797465,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时31分,Corvus Pharmaceuticals, Inc.股票出现波动,股价快速上涨20.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Osr Holdings Inc C/Wts 09/02/2028 、Corvus Pharmaceuticals, Inc.、艾切托涨幅较大,Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为424.20%、112.58%、10.46%,振幅较大的相关个股有Protalix Biotherapeutics, Inc. 、Prokidney Corp.、Assembly Biosciences, Inc.,振幅分别为15.22%、12.80%、11.08%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213105a4783c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213105a4783c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","CRVS","BK4139"],"gpt_icon":0},{"id":"2534169921","title":"Corvus Pharma(CRVS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.13美元,前值为-0.12美元,预期值为-0.12美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534169921","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534169921?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:12","pubTimestamp":1746735140,"startTime":"0","endTime":"0","summary":"Corvus Pharma(CRVS.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.13美元,前值为-0.12美元,预期值为-0.12美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09041250242981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRVS"],"gpt_icon":0},{"id":"2534115173","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534115173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534115173?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:00","pubTimestamp":1746720054,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日00时00分,Corvus Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.46%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509000054975367b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509000054975367b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVS","BK4568"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corvusbiotech.com","stockEarnings":[{"period":"1week","weight":0.053},{"period":"1month","weight":-0.0048},{"period":"3month","weight":0.291},{"period":"6month","weight":-0.1184},{"period":"1year","weight":1.085},{"period":"ytd","weight":-0.2206}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corvus Pharmaceuticals, Inc.于2014年1月27日在特拉华州注册成立,并于2014年11月开始运作。该公司是一家临床阶段的生物制药公司,专注于发展和商业化那些旨在利用免疫系统攻击癌细胞的新免疫治疗肿瘤方案。自从2014年11月开始运营起,已建成四个免疫肿瘤的方案,其中三个重点腺苷癌症轴调节免疫反应的管道。该公司的主导候选产品,CPI-444,A2A受体腺苷,免疫检查点的口服小分子拮抗剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.022575},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.054432},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.007101},{"month":4,"riseRate":0.4,"avgChangeRate":-0.074037},{"month":5,"riseRate":0.7,"avgChangeRate":0.293143},{"month":6,"riseRate":0.3,"avgChangeRate":-0.062415},{"month":7,"riseRate":0.5,"avgChangeRate":0.054478},{"month":8,"riseRate":0.666667,"avgChangeRate":0.121396},{"month":9,"riseRate":0.444444,"avgChangeRate":0.086364},{"month":10,"riseRate":0.333333,"avgChangeRate":0.009486},{"month":11,"riseRate":0.555556,"avgChangeRate":-0.010791},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.055784}],"exchange":"NASDAQ","name":"Corvus Pharmaceuticals, Inc.","nameEN":"Corvus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corvus Pharmaceuticals, Inc.,CRVS,Corvus Pharmaceuticals, Inc.股票,Corvus Pharmaceuticals, Inc.股票老虎,Corvus Pharmaceuticals, Inc.股票老虎国际,Corvus Pharmaceuticals, Inc.行情,Corvus Pharmaceuticals, Inc.股票行情,Corvus Pharmaceuticals, Inc.股价,Corvus Pharmaceuticals, Inc.股市,Corvus Pharmaceuticals, Inc.股票价格,Corvus Pharmaceuticals, Inc.股票交易,Corvus Pharmaceuticals, Inc.股票购买,Corvus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corvus Pharmaceuticals, Inc.(CRVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corvus Pharmaceuticals, Inc.(CRVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}